Decitabine and Cough aggravated - a phase IV clinical study of FDA data

Summary:

Cough aggravated is reported as a side effect among people who take Decitabine (decitabine), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Acyclovir, and have Acute myeloid leukaemia.

The phase IV clinical study analyzes which people have Cough aggravated when taking Decitabine. It is created by eHealthMe based on reports of 4,601 people who have side effects when taking Decitabine from the FDA, and is updated regularly.

What is Decitabine?

Decitabine has active ingredients of decitabine. eHealthMe is studying from 4,605 Decitabine users. Check the latest studies of Decitabine.

What is Cough aggravated?

Cough aggravated is found to be associated with 2,453 drugs and 904 conditions by eHealthMe. Check the latest studies of Cough aggravated.

On Aug, 11, 2026

4,601 people reported to have side effects when taking Decitabine.
Among them, 72 people (1.56%) have Cough aggravated.

Could Decitabine cause Cough aggravated?

Among these 72 people:

How long have people been on Decitabine when they have Cough aggravated? *

What is the gender of people who have Cough aggravated when taking Decitabine? *

female: 30 %
male: 70 %

What is the age of people who have Cough aggravated when taking Decitabine? *

What are other drugs people take besides Decitabine? *

What are other side effects people have besides Cough aggravated? *

Thrombocytopenia (decrease of platelets in blood): 24 people, 33.33%
Dyspnea (difficult or laboured breathing): 23 people, 31.94%
Fever: 23 people, 31.94%
Diarrhea: 20 people, 27.78%
Constipation: 17 people, 23.61%
Nausea (feeling of having an urge to vomit): 14 people, 19.44%
Febrile Neutropenia (fever with reduced white blood cells): 13 people, 18.06%
Anaemia (lack of blood): 12 people, 16.67%
Fatigue (feeling of tiredness): 12 people, 16.67%
Pneumonia: 11 people, 15.28%

What are the existing conditions these people have? *

Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 29 people, 40.28%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 9 people, 12.50%
Chondrosarcoma (common form of bone cancer): 4 people, 5.56%
Colon Cancer Metastatic (cancer of colon spreads to other part of body): 4 people, 5.56%
Musculoskeletal Pain (pain affects the bones, muscles, ligaments, tendons, and nerves): 3 people, 4.17%
Anaemia (lack of blood): 3 people, 4.17%
Idiopathic Thrombocytopenic Purpura (bleeding disorder in which the immune system destroys platelets, which are necessary for normal blood clotting): 3 people, 4.17%
Metastatic Malignant Melanoma (spreadable cancer tumour of melanine): 2 people, 2.78%
Type 2 Diabetes: 1 person, 1.39%
Colorectal Cancer Metastatic (cancer of colon and rectal spreads to other parts): 1 person, 1.39%

* Approximation only. Some reports may have incomplete information.

Do you take Decitabine and have Cough aggravated?

- Check whether Cough aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Decitabine:

Decitabine (4,605 reports)

Browse all side effects of Decitabine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Cough aggravated:

Cough aggravated (2,453 drugs)

Browse all the conditions that are associated with Cough aggravated:

Cough aggravated (904 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on decitabine (the active ingredients of Decitabine) and Decitabine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.